Results 151 to 160 of about 206,749 (211)
Some of the next articles are maybe not open access.

Molecular structure of the .beta.-adrenergic receptor

Biochemistry, 1985
The beta-adrenergic receptor from several tissues has been purified to homogeneity or photoaffinity radiolabeled and its subunit molecular weight determined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. In this study we have examined the oligomeric structure of nondenatured beta 1- and beta 2-adrenergic receptor proteins, as ...
Darrell R. McCaslin   +6 more
openaire   +3 more sources

Tocolysis with beta-adrenergic receptor agonists

Seminars in Perinatology, 2001
Beta-adrenergic receptor agonists have been used for tocolysis in the setting of preterm labor for more than three decades. One of these agents, ritodrine hydrochloride, is the only Federal Drug Administration (FDA) approved drug for the treatment of preterm labor.
Julian T. Parer, Aaron B. Caughey
openaire   +3 more sources

Antibodies to Beta-Adrenergic Receptors

1991
Contemporary biochemists and molecular biologists strive to understand the relationship between the function and the detailed chemical structure of macromolecules. Whereas chemical and direct physical analyses are employed to probe molecular structure, specific antibodies to proteins have been invaluable reagents in the determination of the fine ...
Harvey J. Brandwein   +2 more
openaire   +2 more sources

BETA‐ADRENERGIC RECEPTOR ANTAGONISM IN MYOPIA*

Ophthalmic and Physiological Optics, 1987
Abstract— A previous study has demonstrated that timolol maleate (0.5%), a non‐selective beta‐adrenergic antagonist, produces in emmetropes a significant reduction in accommodative convergence (AC) during the initial four minutes of a near‐vision task.
Mark Rosenfield, Bernard Gilmartin
openaire   +3 more sources

The Beta-Adrenergic Receptor in Heart Failure

Hospital Practice, 1983
Although the role of the autonomic nervous system in the pathophysiology of heart failure has been studied for decades, only within the past few years have adrenergic receptors and their alterations occupied center stage. There is now considerable evidence linking such receptors to many of the phenomena of heart failure; recent work appears to have ...
Robert J. Lefkowitz, James A. Heinsimer
openaire   +3 more sources

Modulation of porcine adipocyte beta-adrenergic receptors by a beta-adrenergic agonist.

Journal of Animal Science, 2000
Mammalian cells have several mechanisms to decrease the response to beta-adrenergic agonists. Agonists are metabolized or taken up by nerve endings. The beta-adrenergic receptors (betaAR) are inactivated by phosphorylation and removed from the cell membrane, and synthesis is decreased or degradation is increased.
Shih-Torng Ding   +3 more
openaire   +3 more sources

Perspectives in adrenergic beta‐receptor blockade

Clinical Pharmacology & Therapeutics, 1969
The adrenergic ß‐receptor blocking drugs currently undergoing clinical evaluation are classified in relation to their pharmacological properties. Particular consideration is given to those pharmacological properties that may be of importance in the clinical application of these drugs.
openaire   +3 more sources

Reduction of beta-adrenergic receptors by tertatolol: An additional mechanism for beta-adrenergic blockade

Clinical Pharmacology and Therapeutics, 1986
Tertatolol is a potent new beta-blocker with no intrinsic sympathomimetic activity or beta 1/beta 2-receptor subtype selectivity. When given at therapeutic doses (5 mg/day) to human subjects it induced a reduction in the beta-adrenergic receptor number measured by 3H-CGP 12177 specific binding, without any change in the affinity on intact lymphocytes ...
DE BLASI, ANTONIO   +5 more
openaire   +4 more sources

Solubilization of a mammalian ?-adrenergic receptor

Naunyn-Schmiedeberg's Archives of Pharmacology, 1978
Binding sites for iodohydroxybenzylpindolol with characteristics of a beta2-adrenergic receptor have been identified in a crude membrane fraction from guinea-pig lung. The binding sites could be solubilized by treatment of the membrane fraction with digitonin.
J, Kleinstein   +3 more
openaire   +3 more sources

Pharmacogenetics of Beta-1- and Beta-2-Adrenergic Receptors

Pharmacology, 2000
β<sub>1</sub>- and β<sub>2</sub>-adrenergic receptors are G protein-coupled receptors expressed throughout the body and serve as receptors for the catecholamines epinephrine and norepinephrine. They are targets for therapeutive agonists and/or antagonists in treatment of heart failure and asthma.
openaire   +3 more sources

Home - About - Disclaimer - Privacy